Status:
NOT_YET_RECRUITING
A Prospective, Multi-center, Randomized Clinical Trial to Evaluate the Detection of Atrial Fibrillation Using Artificial Intelligence-Enhanced Electrocardiography (SmartECG-AFrisk) Compared With Usual Care in Patients With Suspected Atrial Fibrillation: DEEP-AF
Lead Sponsor:
Yonsei University
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
30+ years
Phase:
NA
Brief Summary
"The DEEP-AF study is a prospective, multi-center, randomized clinical trial evaluating the effectiveness of an artificial intelligence-enhanced electrocardiography algorithm (SmartECG-AFrisk) for ear...
Eligibility Criteria
Inclusion
- \- Adults ≥30 years old
- \- Symptoms suggestive of atrial fibrillation (palpitations, dizziness, syncope, dyspnea, chest discomfort)
- \- No evidence of AF on baseline 12-lead ECG
- \- No prior history of AF diagnosis
Exclusion
- \- Prior diagnosis of atrial fibrillation
- \- Life expectancy ≤ 1 year
Key Trial Info
Start Date :
November 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2027
Estimated Enrollment :
1230 Patients enrolled
Trial Details
Trial ID
NCT07173673
Start Date
November 1 2025
End Date
November 30 2027
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yonsei University College of Medicine
Seoul, South Korea